Patents, Licenses and Drug Prices
Supreme Court Case Could Threaten America’s Ability to Lower Exorbitant Drug Prices, New Policy Brief Warns
DEEP DIVE OPINION: Increasing access to medicines: A critical look at pharmaceutical patents
Patently Dumb: America’s current patent system inhibits innovation. Here’s how to fix it
Under pressure, Gilead expands Sovaldi licensing deal to four middle-income countries
AbbVie’s New Hepatitis C Treatment Won’t Cure Patient Access Issue
WHO moves to widen access to generic Sovaldi in dozens of countries